DEXAPOLCORT, 0.28 mg/g, skin spray, suspension
Dexamethasone
Dexapolcort - skin spray, suspension - contains the active substance dexamethasone, which is a corticosteroid. It has anti-inflammatory, antipruritic, anti-allergic, and vasoconstrictive effects.
Dexapolcort is indicated for topical use in corticosteroid-responsive skin diseases:
Tell your doctor or pharmacist about all medicines you are taking or have recently taken, as well as any medicines you plan to use.
During treatment, do not use other topical medicines at the same time, as this may affect the concentrations of the active substances at the site of application and cause interactions or skin irritation.
If you are pregnant or breastfeeding, think you may be pregnant, or plan to have a child, ask your doctor for advice before using this medicine.
If you are pregnant or think you may be pregnant
Do not use Dexapolcort during pregnancy unless your doctor considers it necessary.
If you are breastfeeding
Your doctor will decide whether to use the Dexapolcort spray while you are breastfeeding.
There is no data on the effect of the medicine on the ability to drive or operate machinery.
Dexapolcort should be used as directed by your doctor.
In case of doubts, consult your doctor again.
The medicine is intended for topical use.
Recommended dose
Spray the affected areas of the skin with a stream of suspension, holding the can upright, with the spray head up, at a distance of 15-20 cm, for 1-3 seconds. The medicine is usually used 2-4 times a day at equal intervals.
Highly flammable aerosol. Do not spray near an open flame or other ignition source.
Note: Protect your eyes from the sprayed substance.
Do not inhale the sprayed substance.
After each application, wash your hands thoroughly with soap and water.
Shake the can vigorously before use
Your doctor will determine the appropriate duration of treatment.
If you feel that the effect of the medicine is too strong or too weak, consult your doctor.
After prolonged use on large areas of the skin, in large doses, under occlusive dressings, or on damaged skin, the medicine may be absorbed into the blood and cause systemic effects of corticosteroids (see section 2).
In case of accidental ingestion, contact your doctor or go to the nearest emergency department immediately. Take the medicine in its original packaging so that the medical staff can check which medicine was used.
If you miss a dose at the usual time, use the medicine as soon as possible, and then continue with regular use.
Do not use a double dose to make up for a missed dose.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Dexapolcort may cause local side effects, such as:
burning, itching, irritation at the site of application, excessive drying, atrophic changes, contact dermatitis, perioral dermatitis, maceration, acne-like changes, striae, folliculitis, rash, hirsutism, skin discoloration, secondary skin infections, and folliculitis.
During prolonged use of the spray and/or on large areas of the skin, dexamethasone may be absorbed into the blood and cause systemic side effects characteristic of corticosteroids, including adrenal suppression. In children and infants, growth and development disorders may also occur (see section 2, Warnings and Precautions).
If you experience any side effects, including any not listed in this leaflet, please tell your doctor, pharmacist, or nurse. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products, Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, Tel.: +48 22 49 21 301; fax: +48 22 49 21 309, e-mail: ndl@urpl.gov.pl. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep the medicine out of the sight and reach of children.
Store at a temperature below 25°C.
Do not use this medicine after the expiry date (EXP) stated on the packaging .
The expiry date refers to the last day of the month.
The active substance of the medicine is dexamethasone.
1 g of suspension contains 0.28 mg of dexamethasone.
The other ingredients are: sorbitan trioleate, lecithin, isopropyl myristate, a mixture: isobutane 72%, n-butane 4%, propane 24%.
Homogeneous suspension, white or almost white in color.
Packaging:a can containing 16.25 g or 32.5 g of suspension, in a cardboard box.
Tarchomińskie Zakłady Farmaceutyczne "Polfa" Spółka Akcyjna, ul. A. Fleminga 2, 03-176 Warsaw, Phone: 22 811-18-14. For more detailed information, please contact the representative of the marketing authorization holder.
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.